- Home
- FMN vs CRVO Comparison
FMN vs CRVO Comparison
Compare FMN & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FMN | CRVO |
|---|---|---|
| Founded | 2002 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.9M | 89.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FMN | CRVO |
|---|---|---|
| Price | $11.10 | $8.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $21.50 |
| AVG Volume (30 Days) | 22.8K | ★ 79.7K |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,159,786.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.09 | $1.80 |
| 52 Week High | $11.31 | $16.94 |
Technical Indicators
Market Signals| Indicator | FMN | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 46.46 | 49.04 |
| Support Level | $11.06 | $8.13 |
| Resistance Level | $11.24 | $9.22 |
| Average True Range (ATR) | 0.07 | 0.61 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 37.50 | 25.91 |
Price Performance
Historical ComparisonAbout FMN Federated Hermes Premier Municipal Income Fund
Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.